Relevance of newly acquired mutations to the prognosis of patients with relapsed multiple myeloma

Pol Arch Intern Med. 2020 Jun 25;130(6):473-475. doi: 10.20452/pamw.15446. Epub 2020 Jun 25.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols
  • Cytogenetic Analysis
  • Humans
  • Multiple Myeloma*
  • Mutation
  • Prognosis